Troy Noordenbos
- Rheumatology top 1%
- Spondyloarthritis Studies and Treatments 12
- Rheumatoid Arthritis Research and Therapies 7
- Urticaria and Related Conditions 3
- Hematology top 5%
- Autoimmune and Inflammatory Disorders Research 6
- Immunology top 5%
- Mast cells and histamine 5
- Psoriasis: Treatment and Pathogenesis 5
- IL-33, ST2, and ILC Pathways 3
- Dermatology top 5%
-
- CAR-T cell therapy research 2
- Co-authors
- Dominique BaetenPaul P. TakNataliya YeremenkoJuan D. CañeteCarmen A. AmbarusMarleen van de SandeTineke CantaertHulda S. Hreggvidsdottir
- Cited by
- RheumatologyHematologyImmunology
- Journals
- New England Journal of Medicine (1 paper)Annals of the Rheumatic Diseases (4 papers)Journal of Leukocyte Biology (1 paper)
- Partner nations
- NetherlandsSpainUnited States
In The Last Decade
Troy Noordenbos
20 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Rheumatology 629
- Hematology 321
- Immunology 591
- Dermatology 76
- Immunology and Allergy 33
Countries citing papers authored by Troy Noordenbos
This map shows the geographic impact of Troy Noordenbos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Troy Noordenbos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Troy Noordenbos more than expected).
Fields of papers citing papers by Troy Noordenbos
This network shows the impact of papers produced by Troy Noordenbos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Troy Noordenbos. The network helps show where Troy Noordenbos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Troy Noordenbos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapybreakdown → | 2024 | 93 |
| 2 | 2024 | 3 | |
| 3 | 2018 | 34 | |
| 4 | 2018 | 28 | |
| 5 | 2016 | 18 | |
| 6 | 2016 | 67 | |
| 7 | 2015 | 4 | |
| 8 | 2014 | 2 | |
| 9 | 2014 | 3 | |
| 10 | 2013 | 96 | |
| 11 | 2012 | 52 | |
| 12 | 2012 | 120 | |
| 13 | 2011 | 226 | |
| 14 | 2011 | 1 | |
| 15 | 2010 | 1 | |
| 16 | 2009 | 130 | |
| 17 | 2009 | 38 | |
| 18 | 2009 | 11 | |
| 19 | 2008 | 59 | |
| 20 | 2008 | 47 |
About Troy Noordenbos
Troy Noordenbos is a scholar working on Rheumatology, Hematology and Immunology, having authored 21 papers that have together received 1.0k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (12 papers), Rheumatoid Arthritis Research and Therapies (7 papers), Autoimmune and Inflammatory Disorders Research (6 papers), Mast cells and histamine (5 papers), Psoriasis: Treatment and Pathogenesis (5 papers), Urticaria and Related Conditions (3 papers), IL-33, ST2, and ILC Pathways (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Rheumatology (629 citations), Hematology (321 citations) and Immunology (591 citations). Troy Noordenbos has collaborated with scholars based in Netherlands, Spain and United States. Frequent co-authors include Dominique Baeten, Paul P. Tak, Nataliya Yeremenko, Juan D. Cañete, Carmen A. Ambarus, Marleen van de Sande, Tineke Cantaert, Hulda S. Hreggvidsdottir, Bernard Vandooren and Iris C. Blijdorp. Their work appears in journals such as New England Journal of Medicine, Annals of the Rheumatic Diseases and Journal of Leukocyte Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.